Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review

The challenge to find the best predictors of conversion from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD) has been ongoing at least for the last decade. Nonetheless, clinicians still lack, to date, a robust predictive tool for identifying individuals who will go through this conversio...

Description complète

Détails bibliographiques

Auteurs principaux:	Lea Daou, Alaeddine El Alayli, Fadi Constantinos, Georgette Dib, Marc Barakat
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2023-12-01
Collection:	Biomarkers in Neuropsychiatry
Sujets:	Mild cognitive impairment Alzheimer's disease Neurocognitive assessment Neuropsychological testing Predictive accuracy Biomarkers
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2666144623000096
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!